FDA Inspection
LifeShare Blood CentersLifeShare Blood Centers – FDA Inspection, Nov 4, 2024
Record Details
This FDA Inspection record concerns LifeShare Blood Centers, with an inspection on November 4, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · af587107-e663-4fa6-9374-e6757e70dff7
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1254262
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of LifeShare Blood Centers
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 24, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 3, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 17, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 5, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 17, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for LifeShare Blood Centers
- FDA Inspection 1098161 - 2019-06-24
- FDA Inspection 995056 - 2016-11-03
- FDA Inspection 900426 - 2014-10-17
- FDA Inspection 826041 - 2013-04-05
- FDA Inspection 730854 - 2011-06-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.